---
title: "NLS Pharmaceutics (NLSP.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/NLSP.US/norm.md"
symbol: "NLSP.US"
name: "NLS Pharmaceutics"
parent: "https://longbridge.com/en/quote/NLSP.US.md"
datetime: "2026-05-21T16:13:55.019Z"
locales:
  - [en](https://longbridge.com/en/quote/NLSP.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NLSP.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NLSP.US/norm.md)
---

# NLS Pharmaceutics (NLSP.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.5235 | -0.5235 | -0.4959 | -0.4959 | -0.9707 |
| ROE | -297.52% | -1130.20% | 302.89% | 76.25% | 43.93% |
| Revenue | - | - | - | - | - |
| Net income | -2.10M | -2.10M | -1.01M | -1.01M | -1.02M |

## Balance Sheet (USD)

| Indicator | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 4.34M | 4.34M | 2.23M | 2.23M | 1.19M |
| Leverage | 1.50 | 1.50 | 1.59 | 1.59 | -0.1288 |
| BVPS | 0.6788 | 0.6788 | -0.4224 | -0.4224 | -9.40 |
| Turnover | - | - | - | - | - |

## Cash Flow Statement (USD)

| Indicator | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -1.04M | -1.04M | -1.37M | -1.37M | -765249.00 |
| Investing CF | - | - | -1959.00 | -1959.00 | - |
| Financing CF | 1.74M | 1.74M | 1.93M | 1.93M | 592788.00 |
| Free CF | -531888.00 | -306885.00 | -464233.00 | -5.56M | -609579.00 |